Join to View Full Profile
1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001
Dr. Dai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonResidency, Pathology-Anatomic and Clinical, 2012 - 2016
Kaohsiung Medical CollegeClass of 1999
Certifications & Licensure
MD State Medical License 2023 - 2026
IA State Medical License 2017 - 2024
FL State Medical License 2016 - 2019
TX State Medical License 2017 - 2019
ID State Medical License 2016 - 2018
WA State Medical License 2011 - 2018
AR State Medical License 2016 - 2017
American Board of Pathology Pathology - Anatomic- Join now to see all
Publications & Presentations
PubMed
- Fast Processing of Electron Microscopic Specimen Preserved Ultrastructure of Glomeruli and Electron-Dense Deposits in Diagnostic Renal Biopsies: A Prospective and Retr...Aranza Pinedo, Prerna Rastogi, Abdullah Thayyil, Matthew Gosse, Amy Trent
Modern Pathology. 2025-02-01 - 1 citationsKlotho enhances diastolic function in aged hearts through Sirt1-mediated pathways.Nastaran Daneshgar, Renny Lan, Michael Regnier, Samuel G Mackintosh, Ravinandan Venkatasubramanian
Geroscience. 2024-10-01 - SOX6 expression and aneurysms of the thoracic and abdominal aorta.David Carmona-Berrio, Isabel Adarve-Rengifo, Andrea G Marshall, Zer Vue, Duane D Hall
Iscience. 2024-09-20
Press Mentions
Could Rapamycin Be Our Next Weapon in the Fight for Longevity?September 7th, 2022
Grant Support
- Metabolic reprogramming and FGF21 signaling in kidney health and polycystic kidney diseasesJOHNS HOPKINS UNIVERSITY2023–2027
- Metabolic reprogramming and FGF21 signaling in kidney health and polycystic kidney diseasesJOHNS HOPKINS UNIVERSITY2023–2027
- Metabolic reprogramming and FGF21 signaling in kidney health and polycystic kidney diseasesJOHNS HOPKINS UNIVERSITY2023–2027
- Metabolic reprogramming and FGF21 signaling in kidney health and polycystic kidney diseasesJOHNS HOPKINS UNIVERSITY2023–2027
- The role of energy sensor signaling in mitochondrial cardiomyopathyJOHNS HOPKINS UNIVERSITY2024
- The role of energy sensor signaling in mitochondrial cardiomyopathyJOHNS HOPKINS UNIVERSITY2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
